国产99久久精品_欧美日本韩国一区二区_激情小说综合网_欧美一级二级视频_午夜av电影_日本久久精品视频

荷蘭Delft Imaging Systems   
Delft DI 專門從事兩個領域的業務。第一個領域是為共用數位影像和醫療記錄推出具有創新色彩的醫療軟體解決方案。這項業務未來將變成開發新式醫療保健ICT（資訊通信技術）解決方案（包括跨企業共用成像文檔(XDSI) 解決方案）的平臺。

第二個領域是多種醫院放射科定制解決方案的數位X 射線成像系統、系統集成及服務。在過去十年里，Delft DI 一直都是佳能(Canon) 數位放射成像系統在荷蘭和比利時的分銷合作伙伴。 Delft DI 已經將佳能數位放射成像產品納入該公司的服務之中，而數位X 射線成像系統這項業務將在Delft DI 和Canon Europe 合作的基礎上繼續發展，并將成為開發未來數位放射成像服務的一大平臺。

Delft Imaging Systems is part of Delft Diagnostic Imaging and finds its origin from Oldelft, the company that introduced the world-famous Odelca chest screening camera system in 1950. As a System Integrator we have developed a sharp eye for the practical needs of our customers. This has resulted in market-oriented structure of the company and in products and services which truly extend the boundaries of the possible. Our digital X-ray platform gives Delft a vital advantage over the competitors providing innovative solutions to the limitations that exist on the wider use of digital X-rays. Limitations such as non-availability at peripheral health facilities and the difficulty of interpreting results, even by trained physicians. Delft Imaging Systems is constantly developing new services and products for customers around the globe, has sufficient and adequate facilities and highly qualified personnel to carry out the specific training and application courses for the equipment involved. Traditionally we have a strong network of distributors and agents all around the world. We work closely with various stakeholders and prestigious international institutes that recognize the potential key benefits of direct digital radiology in low resource setting. Investments in low resource setting are often made by governments with financial support of the Global Fund, Gates foundation, programs like ORIO and others. All these donors are advised for their (annual) investments by organizations like the IUATLD and KNCV. Delft has most excellent relations with these donors and with KNCV and IUATLD. Delft Imaging Systems is the only imaging company worldwide to invest in solutions that assist the medical community in the fight against tuberculosis.